Appendix 3X (Initial Director’s Interest Notice) in relation to the appointment of Dr. Hazle effective July 30th, 2018.
View and download Appointment of Director and Appendix 3X.
Imagion Biosystems receives AU$3.5 million in R&D tax incentives
MELBOURNE — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to report that it